Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Stem Cells | 9 | 2026 | 33 | 3.170 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 3 | 2025 | 6 | 1.340 |
Why?
|
| Oligodendroglia | 5 | 2025 | 41 | 1.050 |
Why?
|
| Cell Differentiation | 6 | 2025 | 681 | 0.900 |
Why?
|
| Central Nervous System Diseases | 2 | 2021 | 28 | 0.860 |
Why?
|
| Leukodystrophy, Globoid Cell | 3 | 2023 | 4 | 0.820 |
Why?
|
| Multiple Sclerosis | 5 | 2025 | 77 | 0.780 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2024 | 31 | 0.780 |
Why?
|
| Myelin Sheath | 3 | 2025 | 31 | 0.710 |
Why?
|
| Microglia | 3 | 2019 | 113 | 0.700 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 56 | 0.690 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 12 | 0.680 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2019 | 43 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 171 | 0.540 |
Why?
|
| Stem Cell Transplantation | 2 | 2025 | 191 | 0.360 |
Why?
|
| Signal Transduction | 1 | 2018 | 1748 | 0.350 |
Why?
|
| Animals | 14 | 2026 | 13526 | 0.340 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2019 | 21 | 0.300 |
Why?
|
| Cells, Cultured | 4 | 2020 | 1569 | 0.280 |
Why?
|
| Axons | 2 | 2019 | 44 | 0.270 |
Why?
|
| Lipogenesis | 1 | 2026 | 32 | 0.240 |
Why?
|
| Demyelinating Diseases | 1 | 2025 | 8 | 0.240 |
Why?
|
| Interferons | 1 | 2025 | 39 | 0.230 |
Why?
|
| Isotope Labeling | 1 | 2026 | 60 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 1925 | 0.230 |
Why?
|
| Brain | 3 | 2022 | 1350 | 0.210 |
Why?
|
| Cholesterol | 1 | 2024 | 161 | 0.210 |
Why?
|
| Proteomics | 3 | 2024 | 336 | 0.200 |
Why?
|
| Peptide Fragments | 1 | 2024 | 209 | 0.190 |
Why?
|
| Astrocytes | 2 | 2024 | 139 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 145 | 0.190 |
Why?
|
| Neurogenesis | 1 | 2022 | 29 | 0.180 |
Why?
|
| Humans | 12 | 2026 | 53230 | 0.180 |
Why?
|
| Gliosis | 1 | 2021 | 5 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 412 | 0.180 |
Why?
|
| Neuroglia | 1 | 2021 | 39 | 0.180 |
Why?
|
| Cicatrix | 1 | 2021 | 43 | 0.180 |
Why?
|
| Neurons | 2 | 2024 | 394 | 0.160 |
Why?
|
| Inflammation | 2 | 2022 | 652 | 0.160 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 24 | 0.150 |
Why?
|
| Fibrinogen | 1 | 2019 | 33 | 0.150 |
Why?
|
| Nerve Regeneration | 1 | 2019 | 21 | 0.150 |
Why?
|
| Lipopeptides | 1 | 2019 | 62 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 392 | 0.150 |
Why?
|
| Mice | 7 | 2025 | 5982 | 0.150 |
Why?
|
| Enzyme Activation | 1 | 2018 | 267 | 0.140 |
Why?
|
| Wnt Proteins | 1 | 2018 | 104 | 0.140 |
Why?
|
| beta Catenin | 1 | 2018 | 107 | 0.140 |
Why?
|
| Rats | 2 | 2024 | 3162 | 0.130 |
Why?
|
| Clemastine | 1 | 2016 | 1 | 0.130 |
Why?
|
| Miconazole | 1 | 2016 | 2 | 0.130 |
Why?
|
| Cuprizone | 1 | 2016 | 3 | 0.130 |
Why?
|
| Myelin Basic Protein | 1 | 2016 | 6 | 0.130 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 10 | 0.130 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 49 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 193 | 0.110 |
Why?
|
| Tenascin | 1 | 2014 | 2 | 0.110 |
Why?
|
| Psychosine | 1 | 2014 | 2 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1544 | 0.110 |
Why?
|
| Aging | 1 | 2020 | 714 | 0.110 |
Why?
|
| Apoptosis | 1 | 2016 | 1139 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 1517 | 0.070 |
Why?
|
| Lysophosphatidylcholines | 1 | 2025 | 3 | 0.060 |
Why?
|
| Carbon Isotopes | 1 | 2026 | 73 | 0.060 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2024 | 10 | 0.060 |
Why?
|
| Glutamine | 1 | 2026 | 177 | 0.050 |
Why?
|
| Simvastatin | 1 | 2024 | 28 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 14534 | 0.050 |
Why?
|
| Male | 3 | 2025 | 27435 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2026 | 294 | 0.050 |
Why?
|
| Fibronectins | 1 | 2024 | 36 | 0.050 |
Why?
|
| Glucose | 1 | 2026 | 361 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2023 | 6 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 76 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 910 | 0.050 |
Why?
|
| Aged | 1 | 2016 | 10429 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2024 | 363 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2022 | 13 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 58 | 0.050 |
Why?
|
| Models, Biological | 1 | 2024 | 737 | 0.040 |
Why?
|
| Middle Aged | 1 | 2016 | 13419 | 0.040 |
Why?
|
| Female | 2 | 2019 | 28782 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 694 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 146 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 357 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5595 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3805 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 4162 | 0.010 |
Why?
|